104 related articles for article (PubMed ID: 30041958)
1. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
2. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
[TBL] [Abstract][Full Text] [Related]
4. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
5. High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression.
Liu Y; Liu Y; Li Y; Wang T; Li B; Kong X; Li C
Head Neck; 2024 Jun; 46(6):1450-1467. PubMed ID: 38523407
[TBL] [Abstract][Full Text] [Related]
6. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
7. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract][Full Text] [Related]
8. MIEN1 promotes oral cancer progression and implicates poor overall survival.
Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
[TBL] [Abstract][Full Text] [Related]
9. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.
Rijvers L; Melief MJ; van der Vuurst de Vries RM; Stéphant M; van Langelaar J; Wierenga-Wolf AF; Hogervorst JM; Geurts-Moespot AJ; Sweep FCGJ; Hintzen RQ; van Luijn MM
Eur J Immunol; 2018 Nov; 48(11):1861-1871. PubMed ID: 30160778
[TBL] [Abstract][Full Text] [Related]
10. Identification of activating transcription factor 6 (ATF6) as a novel prognostic biomarker and potential target in oral squamous cell carcinoma.
Wu Y; Xie Q; Wu L; Li Z; Li X; Zhang L; Zhang B
Gene; 2024 Jul; 915():148436. PubMed ID: 38579904
[TBL] [Abstract][Full Text] [Related]
11. High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin YM; Sung WW; Hsieh MJ; Tsai SC; Lai HW; Yang SM; Shen KH; Chen MK; Lee H; Yeh KT; Chen CJ
PLoS One; 2015; 10(11):e0142656. PubMed ID: 26562534
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma.
Hatano K; Saigo C; Kito Y; Shibata T; Takeuchi T
Clin Exp Dent Res; 2020 Apr; 6(2):174-180. PubMed ID: 32250571
[TBL] [Abstract][Full Text] [Related]
13. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
[TBL] [Abstract][Full Text] [Related]
14. The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.
Hu Q; Wu T; Chen X; Li H; Du Z; Hao Y; Peng J; Tai S; Song M; Cheng B
Cancer Med; 2018 Apr; 7(4):1056-1069. PubMed ID: 29479858
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor mediates skin aging via CD74: Insights from single-cell and bulk RNA sequencing data.
Wu S; Ouyang Y; Hu Y; Jiang L; Fu C; Lei L; Zhang Y; Guo H; Huang J; Chen J; Zeng Q
Clin Immunol; 2024 Jun; 263():110199. PubMed ID: 38565329
[TBL] [Abstract][Full Text] [Related]
16. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-related protein 1 as a biomarker of local immune status and worse prognosis of Oral squamous cell carcinoma.
Liu DX; Wu KH; Zang XY; Lu JY; Liu MY; Li CM; Gao L
Technol Health Care; 2024; 32(3):1473-1488. PubMed ID: 38073341
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology.
Wang Z; Kirkwood KL; Wang Y; Du W; Lin S; Zhou W; Yan C; Gao J; Li Z; Sun C; Liu F
J Exp Clin Cancer Res; 2024 Mar; 43(1):94. PubMed ID: 38539232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
